← Leaderboards
Norma P Gerard
Beth Israel Deaconess Medical Center
$6,845,644
Attributed
$7,066,894
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $675.2K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$7,066,894 · 6
By mechanism
R01$4,996,595 · 3
R37$1,496,191 · 1
P50$574,108 · 1
P01$0 · 1
Top collaborators
- Craig J. Gerard1 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Martin R. Pollak$37,233,145
- Michael Scott Seaman$1,441,802
- Agustin Melo Carrillo$475,475
Others in their field
Top investigators on “Anaphylatoxins”
- John D Lambris · Temple University$13,233,741
- Craig J. Gerard · Children'S Hospital Boston$7,263,380
- Rick A. Wetsel · University Of Texas Hlth Sci Ctr Houston$6,319,248
- Wenchao Song · University Of Pennsylvania$6,123,650
- Rekha Bansal · Novelmed Therapeutics, Inc.$6,117,154
- Peter Scott Heeger · Case Western Reserve University$5,639,939
Research focus
AnaphylatoxinsReceptor BindingLungG ProteinLung InjuryComplement ReceptorProtein Structure FunctionBiological Signal TransductionLaboratory MouseInflammationPhosphatidylinositolsLigandsGenetically Modified AnimalsComplement 5aAnimalsAnimal ModelInvestigationImmunopharmacologyGranulocyteGuinea PigsCytokine ReceptorsCellsComplexExtracellular
Grant awards (23)
Targeting Innate Immunity in Staphylococcal Infection$442,500
R01 · FY2020 · AI · contact PI
Targeting Innate Immunity in Staphylococcal Infection$442,500
R01 · FY2019 · AI · contact PI
Targeting Innate Immunity in Staphylococcal Infection$442,500
R01 · FY2018 · AI · contact PI
Targeting Innate Immunity in Staphylococcal Infection$442,500
R01 · FY2017 · AI · contact PI
Targeting Innate Immunity in Staphylococcal Infection$442,500
R01 · FY2016 · AI
Immunopharacology of Complement Anaphylatoxins in Lung$360,546
R01 · FY2008 · HL · contact PI
Immunopharacology of Complement Anaphylatoxins in Lung$360,546
R01 · FY2007 · HL · contact PI
Immunopharacology of Complement Anaphylatoxins in Lung$371,315
R01 · FY2006 · HL · contact PI
Immunopharacology of Complement Anaphylatoxins in Lung$379,688
R01 · FY2005 · HL
Hypoxia, hyperoxia, and airway inflammation$295,552
P50 · FY2005 · HL
CELLULAR AND MOLECULAR BIOLOGY OF NEUROKININS IN LUNG$316,000
R01 · FY2004 · HL
IMMUNOPHARMACOLOGY OF COMPLEMENT ANAPHYLATOXINS IN LUNG$299,527
R37 · FY2004 · HL
CELLULAR AND MOLECULAR BIOLOGY OF NEUROKININS IN LUNG$316,000
R01 · FY2003 · HL
IMMUNOPHARMACOLOGY OF COMPLEMENT ANAPHYLATOXINS IN LUNG$290,802
R37 · FY2003 · HL
CELLULAR AND MOLECULAR BIOLOGY OF NEUROKININS IN LUNG$311,243
R01 · FY2002 · HL
Hypoxia, hyperoxia, and airway inflammation$278,556
P50 · FY2002 · HL
IMMUNOPHARMACOLOGY OF COMPLEMENT ANAPHYLATOXINS IN LUNG$255,000
R37 · FY2002 · HL
IMMUNOPHARMACOLOGY OF COMPLEMENT ANAPHYLATOXINS IN LUNG$55,922
R37 · FY2002 · HL
CELLULAR AND MOLECULAR BIOLOGY OF NEUROKININS IN LUNG$28,757
R01 · FY2002 · HL
CELLULAR AND MOLECULAR BIOLOGY OF NEUROKININS IN LUNG$340,000
R01 · FY2001 · HL
IMMUNOPHARMACOLOGY OF COMPLEMENT ANAPHYLATOXINS IN LUNG$301,867
R37 · FY2001 · HL
Hypoxia, hyperoxia, and airway inflammation$0
P01 · FY2001 · HL
IMMUNOPHARMACOLOGY OF COMPLEMENT ANAPHYLATOXINS IN LUNG$293,073
R37 · FY2000 · HL